Skip to main content
. 2019 Apr 3;17(6):4877–4890. doi: 10.3892/ol.2019.10211

Figure 2.

Figure 2.

CX3CL1 mRNA expression levels in LUSC and at Tumour Node Metastasis stages. (A) In patients with LUSC, the CX3CL1 mRNA expression levels in normal tissue were significantly increased compared with tumour tissue (t=7.762, P<0.001). (B) CX3CL1 mRNA expression levels in stage III were significantly different compared with in stages I and IV (F=4.432, P=0.004; stage III vs. stage I P=0.021, stage III vs. stage IV P=0.036). *P<0.05. CX3CL1, chemokine C-X3-C motif ligand 1; LUSC, lung squamous cell carcinoma.